X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

The risks of counterfeit imported medicines

By Allyson Funk  |    April 20, 2017
A recent Wall Street Journal article laid out the serious concerns posed by potent, counterfeit prescription opioids pouring into the United States from China, Mexico and Canada. The Drug...   Read More

Fighting disease Together: New ads feature patients and the researchers behind today’s breakthroughs

By Robert Zirkelbach  |    April 19, 2017
Today, we launched our next wave of advertising as part of the GOBOLDLY™ campaign, titled Together, featuring the stories of researchers developing cutting-edge breakthroughs alongside patients...   Read More

Trading fair means upholding the law: A focus on patents

By Jay Taylor  |    April 18, 2017
Patents are the linchpin of innovation. In the United States and other countries around the world, they provide temporary protection for new inventions. A fair, stable and predictable patent...   Read More

Mental health in the New Era of Medicine

By Bill Chin, M.D.  |    April 18, 2017
Research and development of innovative medicines to promote mental health are a priority for America’s biopharmaceutical research companies. With more than 130 medicines in development for mental...   Read More

New nonprofit – I-ACT for Children – launches to promote innovative medicines development for young patients in need

By Lucy Vereshchagina  |    April 17, 2017
In an exciting step forward to support research and development of innovative new medicines and devices for pediatric patients, the Critical Path Institute (C-Path) announced the launch of a new...   Read More

Driving innovation through collaboration

By Emma Van Hook  |    April 17, 2017
A new report from Deloitte examines the changing landscape of biopharmaceutical research, as stakeholders across the R&D ecosystem are increasingly coming together to tackle sciences’ most vexing...   Read More

Medicare Monday: Another example of the competitive market at work in Part D

By Nicole Longo  |    April 17, 2017
Hepatitis C is a devastating viral disease that can result in life-threatening and costly complications. Five years ago, the only available treatment for the disease often resulted in debilitating...   Read More

Enforcing unmet trade obligations protects U.S. innovation

By Jay Taylor  |    April 11, 2017
The United States leads the world in medical innovation, helping patients across the globe access the latest life-saving treatments and cures. Trade agreements with other nations serve as the...   Read More

Medicare Monday: What they are saying about MedPAC’s Part B recommendations

By Nicole Longo  |    April 10, 2017
Last week, the Medicare Payment Advisory Commission (MedPAC) voted on a number of recommendations affecting Medicare Part B. These proposed changes could negatively impact patients’ access to Part...   Read More

This is not a special effect: New video shows the destruction of a rogue cell

By Robert Zirkelbach  |    April 10, 2017
In the latest video of our Cells series, part of the GOBOLDLY™ campaign, we witness the destruction of a rogue cell that causes rheumatoid arthritis (RA), a disease that affects 1.3 million...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates